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Early Recanalization After Intravenous Administration of
Recombinant Tissue Plasminogen Activator as Assessed by
Pre- and Post-Thrombolytic Angiography in Acute Ischemic
Stroke Patients
Kyung-Yul Lee, MD, PhD; Sang Won Han, MD; Seo Hyun Kim, MD; Hyo Seok Nam, MD;
Sung Whan Ahn, MD; Dong Joon Kim, MD; Sang Hyun Seo, MD;
Dong Ik Kim, MD; Ji Hoe Heo, MD, PhD
Background and Purpose—Recanalization rates after the intravenous (IV) recombinant tissue plasminogen activator
(rt-PA) treatment have been poorly studied in acute stroke.
Methods—CT angiography was performed before IV rt-PA in all patients and digital subtraction angiography was
undertaken for intra-arterial thrombolysis in cases of no improvement after rt-PA infusion.
Results—Forty-five patients were treated with IV rt-PA. Initial CT angiography showed relevant arterial occlusions in 35
patients. Recanalization after rt-PA therapy was demonstrated by digital subtraction angiography in 7 of the 31 patients
with the occlusion on initial CT angiography: 2/16 in the internal carotid or proximal middle cerebral artery, 3/11 in the
distal middle cerebral artery and 2/4 in the basilar artery occlusion.
Conclusions—The early recanalization rate after IV rt-PA use was very low in cases with large proximal arterial
occlusions. CT angiography before IV rt-PA may be useful for the prediction of its efficacy. (Stroke. 2007;38:192-193.)
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Recanalization rates after intravenous (IV) recombinanttissue plasminogen activator (rt-PA) therapy were esti-
mated in stroke patients treated by combined IV and IA
(intra-arterial) thrombolysis and in those with transcranial
Doppler (TCD) monitoring during IV thrombolysis. Rates
were reported as being between 16.8% and 38%.1–3 However,
in the Interventional Management of Stroke study,1 the dose
of rt-PA used was two-thirds of that used for conventional
therapy, the duration of the infusion was reduced by a half,
and the arterial occlusion before IV rt-PA was not deter-
mined. TCD itself may augment the thrombolytic effect of
rt-PA.3 Therefore, the exact recanalization rate by conven-
tional IV rt-PA has remained uncertain.
Subjects and Methods
Patients with an acute ischemic stroke who were subjected to
thrombolysis were retrospectively analyzed. The inclusion criteria
for thrombolysis appear in our previous reports.4 All CT angiography
(CTA) examinations were performed on a 16-channel (Somatom
Sensation 16; Siemens) system. The source images and the 3-D
reconstructed images at 0.75-mm thickness with 0.3-mm increments
were used for image analysis. After initial brain CTs, a total dose of
0.9-mg/kg rt-PA was given for 60 minutes. Patients showing no
responses to IV rt-PA at the end of infusion (1 hour after the bolus;
improvement of National Institutes of Health Stroke Scale [NIHSS]
score 4) were subjected to further IA thrombolysis.4 When an
arterial occlusion was documented by digital subtraction angiogra-
phy, IA thrombolysis with urokinase was performed.
Recanalization status was classified according to the Thromboly-
sis in Cerebral Infarction (TICI) classification5 (Grade 0, no perfu-
sion; Grade 1, penetration with minimal perfusion; Grade 2a, partial
filling 2⁄3 of the entire vascular territory; Grade 2b, complete filling,
but the filling is slower than normal; Grade 3, complete perfusion).
Results
Forty-five patients were treated with IV rt-PA within 3 hours
of symptom onset. The initial CTAs showed relevant arterial
occlusion in 35 and arterial stenosis in 3 patients. Eight
patients showed rapid clinical improvement after IV rt-PA
infusion. Four of them showed arterial occlusion (supplemen-
tal Table I, available online at http://stroke.ahajournals.org).
Digital subtraction angiographies were performed in the
remaining 37 patients. The median time from the IV rt-PA
bolus to the visualization of the occluded arteries by digital
subtraction angiography was 120 minutes (60 to 365 min-
utes). Early recanalization after IV rt-PA (TICI 2) was
achieved in 7 of the 31 patients (22.6%) whose arterial
occlusion had been found on initial CTAs. The early recan-
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alization was least common in the occlusion of the internal
carotid artery (ICA) or proximal middle cerebral artery
(MCA; M1, 2/16, 12.5%). The recanalization rate was 27.3%
(3/11) in patients with the distal MCA (M2 and distal) and
50% (2/4) in those with basilar artery occlusion. After IA
thrombolysis, the final recanalization was achieved in 20 of
31 patients (Table). The median time from onset to successful
recanalization among those treated with IA thrombolysis was
325 minutes (range 195 to 380 minutes, 13 patients). All of
the 7 patients with initially normal CTAs exhibited acute
cerebral infarctions on follow-up MRIs. Infarctions were in
the perforating arterial territory in 3, and multiple and small
in the MCA territory in 3 patients. There were multiple and
bilateral cerebral and cerebellar infarctions in 1. Atrial fibril-
lation was diagnosed in 3 of those 4 patients with multiple
infarctions.
The median baseline NIHSS score was 13 for 45 patients.
At 30 days, it was 2 (assessed in 36 patients). Fifty percent
(21 of 42 patients assessed) had a good functional outcome at
90 days, defined as modified Rankin Scale score 1. Eigh-
teen of 39 patients with ICA territory infarction showed early
ischemic changes (Alberta Stroke Program Early CT Score
[ASPECTS] 10) on initial brain CT.6 Although good
functional outcomes were frequent in high ASPECTS, it
was not statistically significant (ASPECTS7 in 17/33 and
ASPECTS7 in 1/6, 2 test, P0.19). Two of 7 patients who
showed recanalization after IV rt-PA and 8 of 20 patients who
showed recanalization after combined IV and IA thrombolysis
had good functional outcomes. The mortality rate after 90
days was 13.3% (6 patients) attributable to an intracranial
hemorrhage (1), massive cerebral infarctions (4) or an unde-
fined cause after discharge (1). Symptomatic hemorrhage
occurred in 3 patients (2 in the IV rt-PA group) and 1 of them
who had distal ICA occlusion and treated with IV rt-PA died
3 days after thrombolysis.
Discussion
This study provides data on the efficacy of IV thrombolysis
that is used in clinical practice with the currently recom-
mended drug and dosage. The overall recanalization rate in
this study was 22.6% soon after IV rt-PA therapy. It has been
reported that thrombolytic agents administrated intravenously
cannot readily lyse thrombi occluding a large artery. The
recanalization rates evaluated by angiographies that were
performed before and after IV 2-chain rt-PA treatment (0.12
to 0.75 MIU/kg) were 8% in the extracranial ICA, 26.1% in
the proximal MCA, and 38.1% in the distal MCA occlusion.7
A study using 100 mg of rt-PA demonstrated recanalization
rates of 9% in the ICA, 38.8% in the proximal MCA, and
100% in the distal MCA occlusion.8 Our data are consistent
with those studies in that it shows very low recanalization
rates in the ICA and proximal MCA occlusions.
The present study indicates that CTA at the time of initial
evaluation might predict some of the patients who will
respond poorly to IV rt-PA, and this information may be
helpful in the decision of immediate individualized therapeu-
tic planning. For example, in cases with occlusion at the distal
ICA or proximal MCA segment on the initial CTA, additional
treatment with IA thrombolysis or mechanical clot removal
may be considered from the beginning. However, further
studies are necessary because the number of patients in the
present study was too small to provide conclusive data
regarding recanalization rates in each arterial segment.
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Angiographic Findings of the 31 Patients With Arterial
Occlusion on Initial CTA
Occlusion Site
ICA or Proximal
MCA Distal MCA Basilar Artery
No. of patients 16 11 4
Recanalization after
IV rt-PA
2 (12.5%) 3 (27.3%) 2 (50%)
Final recanalization after
combined IA UK
10 (62.5%) 7 (63.6%) 3 (75%)
IA UK indicates intra-arterial urokinase.
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